Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics' stock shows mixed signals, with positive clinical trial data and FDA designations boosting sentiment, but valuation concerns and recent stock offerings are tempering gains.
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuromuscular disorders.
Dyne Therapeutics, Inc. uses the ticker $DYN for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Dyne Therapeutics, Inc. (DYN) social dominance is up 3866.67% from the previous week.
- Dyne Therapeutics, Inc. (DYN) Galaxy Score™ is up 18.92% from the previous week.
- Dyne Therapeutics, Inc. (DYN) sentiment is up 55.81% from the previous week.
- Dyne Therapeutics, Inc. (DYN) posts created is up 16.67% from the previous week.
Price: $22
Price 24-Hour Time-Series Raw Data
The stock price has pulled back after recent gains, influenced by positive clinical trial data and FDA designations, but tempered by valuation concerns and mixed social media sentiment, particularly regarding recent stock offerings.
24-Hour: 37.24% 7-Day: 30.64% 30-Day: 31.7%
1-Year High: $24.30 on 2025-10-28
1-Year Low: $6.80 on 2025-04-08
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Dyne Therapeutics, Inc. (DYN) is currently AltRank #1,084 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] [------]
[--] Month: [-----] +667
[--] Months: [-----] +204
[--] Year: [-----] +430
1-Year High: [-----] on 2026-02-09
1-Year Low: [--] on 2025-07-27
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +7
[--] Month: [--] +5
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-07-16
1-Year Low: [--] on 2025-10-01
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] -23%
[--] Month: [------] -31%
[--] Months: [---------] -44%
[--] Year: [---------] +1.90%
1-Year High: [-------] on 2025-12-08
1-Year Low: [---] on 2026-01-01
Engagements by network (24h): X: [-----] Reddit: [--] YouTube: [---] TikTok: [--] News: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] -20%
[--] Month: [---] -27%
[--] Months: [-----] -36%
[--] Year: [-----] +24%
1-Year High: [---] on 2025-10-27
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): X: [--] Reddit: [--] YouTube: [--] TikTok: [--] News: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Dyne Therapeutics, Inc. (DYN) in the last [--] hours which is up 12% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -6.40%
[--] Month: [---] -19%
[--] Months: [-----] -43%
[--] Year: [-----] +81%
1-Year High: [---] on 2025-10-27
1-Year Low: [--] on 2025-09-14
The most influential creators that mention Dyne Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @dynetherapeutics | [--] | [--] | [--] | [---] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @Dyne_tx | [--] | [-----] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @myotonicstrong | [--] | [-----] | [--] | [--] |
| @Lola59652 | [--] | [--] | [--] | [--] |
| @parentprojectmd | [--] | [-----] | [--] | [--] |
| @stocket_rocket | [--] | [--] | [--] | [--] |
Sentiment: 84%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 84%
Daily Average: 68%
[--] Week: 67% +24%
[--] Month: 83% +23%
[--] Months: 83% +4%
[--] Year: 83% +10%
1-Year High: 100% on 2025-10-18
1-Year Low: 25% on 2026-01-28
Most Supportive Themes:
- Positive Clinical Data and FDA Designation: (40%) Dyne Therapeutics' ACHIEVE trial for DM1 and FDA breakthrough designations are driving positive sentiment.
- Favorable Analyst Ratings: (30%) Analyst ratings and price targets, with a consensus of Strong Buy and potential upside, are supporting the stock.
- Institutional Ownership: (30%) High institutional ownership and confidence from major funds are contributing to a positive outlook.
Most Critical Themes:
- Valuation Concerns: (100%) Downgrades from some analysts and concerns about valuation are creating caution despite promising clinical data.
Social Dominance: 0.00553%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00553%
Daily Average: 0.018%
[--] Week: 0.024% +0.023%
[--] Month: 0.012% +0.0018%
[--] Months: 0.012% -0.00020000000000000052%
[--] Year: 0.012% -0.011%
1-Year High: 0.068% on 2025-04-29
1-Year Low: 0.0015% on 2025-09-14
Market Dominance: 0.0029%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0029%
Daily Average: 0%
1-Year High: 0.00531% on 2025-03-31
1-Year Low: 0.00124% on 2025-04-11
Market Cap: $2,558,695,747
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,558,695,747
Daily Average: $1,986,693,453
[--] Week: $2,576,807,493 -7.50%
[--] Month: $2,558,695,747 -7%
[--] Months: $2,558,695,747 +50%
[--] Year: $2,558,695,747 +81%
1-Year High: $3,655,279,639 on 2025-12-08
1-Year Low: $773,846,055 on 2025-04-08
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing